Strategic Initiative
Slingshot members are tracking this corporate initiative:
ContraVir to Expand Hepatitis B Portfolio through Strategic Merger Agreement with Ciclofilin Pharmaceuticals
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CTRV | Community voting in process | Ciclofilin Pharmaceuticals | Community voting in process | |||
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: May 31, 2016 Projected Implementation: Q2, 2016 Relevance Tracked Until: Q4, 2016
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
Ciclofilin, Hepatitis B, Cpi-431-32, Hepatitis B Virus, Hbv, Tenofovir
